Naltrexone with bupropion | Search results

Showing 1 to 3 of 3 results for naltrexone with bupropion

Sort by

Naltrexone–bupropion for managing overweight and obesity (TA494)
Evidence-based recommendations on naltrexone–bupropion (Mysimba) for managing overweight and obesity in adults.
Result type
Technology appraisal guidance
Published
12 December 2017
View recommendations for TA494
Show all sections
Sections for TA494
Past appeals and decisions
therapy) 30 September 2016 TA494 Obesity (prolonged-release) - naltrexone-bupropion 12 December 2017 TA621 Osimertinib for...
Obesity: identification, assessment and management (CG189)
This guideline covers identifying, assessing and managing obesity in children (aged 2 years and over), young people and adults.
Result type
Clinical guideline
Last updated
26 July 2023
View recommendations for CG189
Show all sections
Sections for CG189